5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole Basic information
- Product Name:
- 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole
- Synonyms:
-
- 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole
- Benzooxazole-5-boronic acid pinacol ester
- 1,3-Benzoxazole-5-boronic acid, pinacol ester
- 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole
- benzo[d]oxazol-5-ylboronic acid pinacol ester
- Benzo[d]oxazole-5-boronic acid pinacol ester
- Benzooxazole-5-boronic acid pinacol ester 97%
- Benzoxazole-5-boronic Acid Pinacol Ester
- CAS:
- 936902-12-4
- MF:
- C13H16BNO3
- MW:
- 245.08
- Mol File:
- 936902-12-4.mol
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole Chemical Properties
- Melting point:
- 88-93°C
- Boiling point:
- 350.1±15.0 °C(Predicted)
- Density
- 1.14±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- pka
- 0.17±0.10(Predicted)
- form
- solid
- Appearance
- White to yellow Solid
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole Usage And Synthesis
Synthesis
132244-31-6
73183-34-3
936902-12-4
5-Bromobenzoxazole (1 g, 5.05 mmol), pinacol ester of bisboronic acid (1.54 g, 6.06 mmol), potassium acetate (1.49 g, 15.15 mmol) and Pd(dppf)Cl2 (184.76 mg, 0.25 mmol) were used as raw materials, and the above reagents were added to a reaction flask under nitrogen protection, using 1,4-dioxane as solvent. The reaction mixture was stirred at 100 °C for 8 hours. After completion of the reaction, it was cooled to room temperature and the solvent was removed by distillation under reduced pressure. The crude product was purified by column chromatography to afford 1.03 g of the target product benzoxazole-5-boronic acid pinacol ester in white powder form in 83.4% yield.
References
[1] Journal of Medicinal Chemistry, 2017, vol. 60, # 14, p. 6337 - 6352
[2] Patent: CN108503634, 2018, A. Location in patent: Paragraph 0316; 0317; 0320; 0321
[3] Patent: US2016/318895, 2016, A1. Location in patent: Paragraph 0300
[4] Journal of Medicinal Chemistry, 2018, vol. 61, # 23, p. 10724 - 10738
[5] Patent: WO2011/14795, 2011, A2. Location in patent: Page/Page column 94
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazoleSupplier
- Tel
- 001-857-928-2050 or 1-888-588-9418
- sales@chemreagents.com
- Tel
- 021-50795510 4000665055
- sales@accelachem.com
- Tel
- 150-2103-5486 18017383231
- 983544897@qq.com
- Tel
- 4009209199
- sales@9dingchem.com
- Tel
- 027-027-87342388 18086026008
- sales@kaymke.com
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole(936902-12-4)Related Product Information
- 1,3-BENZOXAZOLE-5-CARBOXYLIC ACID
- 4-Benzothiazolecarboxylic acid
- 7-Benzothiazolamine (9CI)
- Benzo[1,2-d:4,5-d]bisthiazole-2,6-diamine (9CI)
- BENZOOXAZOLE-2-CARBOXYLIC ACID METHYL ESTER
- Benzo[d]thiazole-7-carbonitrile
- Benzo[b]thiophen-3-ylaMine hydrochloride
- 5-Benzothiazolecarboxylicacid,methylester(9CI)
- 1-Benzothien-7-ylboronic acid
- benzo[h]isoquinoline
- Benzo[D]oxazol-6-ylboronicacid
- 5-BENZOXAZOLOL
- Benzo[b]thiophene-3-boronic acid pinacol ester, 95%
- 7-Benzothiazolecarboxaldehyde(9CI)
- BENZO[D]ISOXAZOL-7-OL
- BENZO(F)ISOQUINOLINE
- Benzoxazole-6-boronic Acid Pinacol Ester
- 2,1,3-BENZOTHIADIAZOL-4-YLMETHYLAMINE,97%